Virtus ETF Advisers’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-26,429
| Closed | -$62.1K | – | 308 |
|
|
2024
Q4 | $62.1K | Buy |
26,429
+6,081
| +30% | +$14.3K | 0.03% | 438 |
|
|
2024
Q3 | $73.9K | Buy |
20,348
+364
| +2% | +$1.32K | 0.03% | 421 |
|
|
2024
Q2 | $69.5K | Buy |
+19,984
| New | +$69.5K | 0.03% | 433 |
|
|
2022
Q2 | – | Sell |
-27,536
| Closed | -$115K | – | 442 |
|
|
2022
Q1 | $115K | Sell |
27,536
-1,639
| -6% | -$6.85K | 0.05% | 279 |
|
|
2021
Q4 | $151K | Buy |
+29,175
| New | +$151K | 0.06% | 345 |
|
|
2020
Q2 | – | Sell |
-28,428
| Closed | -$170K | – | 451 |
|
|
2020
Q1 | $170K | Sell |
28,428
-4,149
| -13% | -$24.8K | 0.07% | 283 |
|
|
2019
Q4 | $430K | Buy |
32,577
+16,179
| +99% | +$214K | 0.07% | 233 |
|
|
2019
Q3 | $204K | Sell |
16,398
-913
| -5% | -$11.4K | 0.04% | 250 |
|
|
2019
Q2 | $279K | Buy |
17,311
+8,877
| +105% | +$143K | 0.06% | 249 |
|
|
2019
Q1 | $265K | Sell |
8,434
-1,068
| -11% | -$33.6K | 0.56% | 71 |
|
|
2018
Q4 | $312K | Buy |
+9,502
| New | +$312K | 0.05% | 98 |
|